Sort   by:  
 Page size 
UnknownMagrolimab plus rituximab with or without chemotherapy in patients with relapsed/refractory diffuse large B-cell lymphoma.
Not available
S-EPMC11609519 | biostudies-literature
UnknownMagrolimab plus rituximab in relapsed/refractory indolent non-Hodgkin lymphoma: 3-year follow-up of a phase 1/2 trial.
Not available
S-EPMC11609520 | biostudies-literature
UnknownCD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin's Lymphoma.
Not available
S-EPMC8058634 | biostudies-literature
UnknownA defect in myoblast fusion underlies Carey-Fineman-Ziter syndrome.
Not available
S-EPMC5504296 | biostudies-literature
UnknownElective surgery cancellations due to the COVID-19 pandemic: global predictive modelling to inform surgical recovery plans.
Not available
S-EPMC7272903 | biostudies-literature
Sort   by:  
 Page size